This essay focuses on successful in treating patients. Also known as indication specific pricing or indication value-base pricing. Since drugs can be use for different indications. This form of pricing would set different prices for each indication base
Complete the following Section of the Propspectus topic- ” Relationship between Patient care and ability to pay”. Develop the Nature of your Study: The nature of the study should include the following. Research method: quantitative, qualitative, or the mix methods. Research design in alignment with your research method Data need,
Also known as indication specific pricing or indication value-based pricing. Since drugs can be use for different indications. This form of pricing would set different prices for each indication base. On the value the drug offers for whatever it is being use to treat. This pricing scheme is often discuss in relation to oncology drugs. Which are costly and not always successful in treating patients.
Oncology drugs can be used for multiple different types of cancers so by applying indication-specific pricing. The drug would be price base on how effective it is for treating each type of cancer. If the drug is more effective for Cancer A than Cancer B. Then the patient taking the drug to treat Cancer A will pay more. The person using it for Cancer B because they are getting more value out of it.
Regardless of what they’re being use for or how effective they are at improving outcomes. Companies like CVS and Express Scripts in the US have begin implementing. Pricing base on indication and in countries like Italy. Similar forms of pricing are already being use. For example, Express Scripts’ “Oncology Care Value Program,. Uses indication-base pricing for certain oncology medications and was launch in 2016.
Italy on the other hand, uses a model similar to indication-base pricing. Where the amount the hospital pays for certain drugs varies base on what it’s use for. Patients can receive reimbursements for treatments base on their response and either be fully or partially refund. Italy’s reimbursement system is run by AIFA, the Italian Medicines Agency. Which is the national authority that regulates drugs in Italy.